pacylex.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Pacylex Pharmaceuticals, |
| Description | MAKING A REAL DIFFERENCE IN Pacylex Pharmaceuticals, Inc. is developing a precision medicine solution for multiple common cancers. Our approach exploits a previously-unknown therapeutic target in cancer, making our drug a first-in-kind |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 75.2.70.75 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
pacylex.com Valuation
|
US$1,711,793
Last updated: 2023-04-29 02:21:35
pacylex.com has Semrush global rank of 6,183,171. pacylex.com has an estimated worth of US$ 1,711,793, based on its estimated Ads revenue. pacylex.com receives approximately 197,515 unique visitors each day. Its web server is located in United States, with IP address 75.2.70.75. According to SiteAdvisor, pacylex.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,711,793 |
| Daily Ads Revenue | US$1,581 |
| Monthly Ads Revenue | US$47,404 |
| Yearly Ads Revenue | US$568,842 |
| Daily Unique Visitors | 13,168 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| pacylex.com. | A | 600 | IP: 75.2.70.75 |
| pacylex.com. | A | 600 | IP: 99.83.190.102 |
| pacylex.com. | NS | 3600 | NS Record: ns74.domaincontrol.com. |
| pacylex.com. | NS | 3600 | NS Record: ns73.domaincontrol.com. |
| pacylex.com. | MX | 3600 | MX Record: 0 mail.pacylex.com. |
| pacylex.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
| pacylex.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| pacylex.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
| pacylex.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
| pacylex.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| pacylex.com. | TXT | 3600 | TXT Record: google-site-verification=LyNJ6VaILfOLkDVcv37cr2W6P-f717gT1DGSMTJ5O2s |
| pacylex.com. | TXT | 3600 | TXT Record: v=spf1 a mx ptr include:secureserver.net ~all |
HtmlToTextCheckTime:2023-04-29 02:21:35
| + home + about + team + pipeline + news + contact About Team Pipeline News Contact MAKING A REAL DIFFERENCE IN CANCER Learn How 57% Our sensitivity biomarker is found in 19 types of cancer at a prevalence (by type). We show that NMT2 expression is lost in numerous cancers. 23% Update Pacylex Pharmaceuticals Announces New Executive Team Members as the Company Accelerates Clinical Development of PCLX-001 Read More Overview Pacylex: Targeting myristoylation to selectively kill cancer. Pacylex is developing PCLX-001, a first-in-class, once daily, oral cancer therapy with a novel, broad, mechanism of action. PCLX-001 attacks the membrane-associated proteins at the root of cancer signaling in leukemia and lymphoma. By interrupting cancer signaling before it spreads to redundant pathways, PCLX-001 offers a potent alternative to classic chemotherapies and immunotherapies to kill cancer cells. In an ongoing Phase 1 clinical trial, PCLX-001 has excellent bioavailability, half-life, safety |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Thu, 21 Oct 2021 23:43:42 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://pacylex.com/ HTTP/2 301 server: openresty date: Thu, 21 Oct 2021 23:43:43 GMT content-type: text/html content-length: 166 location: https://www.pacylex.com/ HTTP/2 200 server: openresty date: Thu, 21 Oct 2021 23:43:43 GMT content-type: text/html content-length: 39255 content-security-policy: frame-ancestors 'self' x-frame-options: SAMEORIGIN x-lambda-id: 1522283c-689d-4f63-b7ba-c11dfbc524e5 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 5930 x-served-by: cache-dca12920-DCA, cache-bwi5079-BWI x-cache: HIT, MISS x-cache-hits: 1, 0 x-timer: S1634859823.260113,VS0,VE3 vary: Accept-Encoding x-cluster-name: us-east-1-prod-edge-eks-15 |
pacylex.com Whois Information
Domain Name: PACYLEX.COM Registry Domain ID: 1749178076_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-10-02T17:46:08Z Creation Date: 2012-10-01T17:01:27Z Registry Expiry Date: 2021-10-01T17:01:27Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS73.DOMAINCONTROL.COM Name Server: NS74.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T18:29:25Z <<< |